cdp ethanolamine has been researched along with Diabetes Mellitus, Type 2 in 1 studies
*Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; He, X; Huang, L; Kong, Q; Li, W; Lu, W; Wang, S; Wang, Y; Xu, B; Xu, H; Xu, W; Xu, Y | 1 |
1 other study(ies) available for cdp ethanolamine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Phosphoethanolamine cytidylyltransferase ameliorates mitochondrial function and apoptosis in hepatocytes in T2DM in vitro.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Diabetes Mellitus, Type 2; Ethanolamines; Hepatocytes; Mice; Mitochondria; Phosphatidylethanolamines; RNA Nucleotidyltransferases | 2023 |